Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease

CONTEXT AND OBJECTIVE: Accurate determination of the Gleason score in prostate core biopsy specimens is crucial in selecting the type of prostate cancer treatment, especially for patients with well-differentiated tumors (Gleason score 2 to 4). For such patients, an inaccurate biopsy score may result in a therapeutic intervention that is too conservative. We evaluate the role of Gleason score 2-4 in prostate core-needle biopsies for predicting the final pathological staging following radical prostatectomy. DESIGN AND SETTING: Retrospective study at Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo. METHODS: We analyzed the medical records of 120 consecutive patients who underwent radical retropubic prostatectomy to treat clinical localized prostate cancer at our institution between December 2001 and July 2006. Thirty-two of these patients presented well-differentiated tumors (Gleason score 2 to 4) in biopsy specimens and were included in the study. The Gleason scores of the core-needle biopsies were compared with the pathological staging of the surgical specimens. RESULTS: Sixteen of the 32 patients (50%) presented moderately differentiated tumors (Gleason score 5 to 7) in surgical specimens. Eighteen patients (56%) had tumors with involvement of the prostate capsule and ten (31%) had involvement of adjacent organs. Evaluating the 16 patients that maintained Gleason scores of 2 to 4 in the pathological staging of the surgical specimens, 11 (68.7%) had focal invasion of the prostate capsule and five (31.25%) had organ-confined disease. CONCLUSION: Well-differentiated tumors (Gleason score 2 to 4) seen in biopsies are not predictive of organ-confined disease.

Saved in:
Bibliographic Details
Main Authors: Cury,José, Coelho,Rafael Ferreira, Srougi,Miguel
Format: Digital revista
Language:English
Published: Associação Paulista de Medicina - APM 2008
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000200010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-31802008000200010
record_format ojs
spelling oai:scielo:S1516-318020080002000102008-06-09Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic diseaseCury,JoséCoelho,Rafael FerreiraSrougi,Miguel Prostate Prostate cancer Prostatic neoplasms Pathology Pathology, surgical CONTEXT AND OBJECTIVE: Accurate determination of the Gleason score in prostate core biopsy specimens is crucial in selecting the type of prostate cancer treatment, especially for patients with well-differentiated tumors (Gleason score 2 to 4). For such patients, an inaccurate biopsy score may result in a therapeutic intervention that is too conservative. We evaluate the role of Gleason score 2-4 in prostate core-needle biopsies for predicting the final pathological staging following radical prostatectomy. DESIGN AND SETTING: Retrospective study at Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo. METHODS: We analyzed the medical records of 120 consecutive patients who underwent radical retropubic prostatectomy to treat clinical localized prostate cancer at our institution between December 2001 and July 2006. Thirty-two of these patients presented well-differentiated tumors (Gleason score 2 to 4) in biopsy specimens and were included in the study. The Gleason scores of the core-needle biopsies were compared with the pathological staging of the surgical specimens. RESULTS: Sixteen of the 32 patients (50%) presented moderately differentiated tumors (Gleason score 5 to 7) in surgical specimens. Eighteen patients (56%) had tumors with involvement of the prostate capsule and ten (31%) had involvement of adjacent organs. Evaluating the 16 patients that maintained Gleason scores of 2 to 4 in the pathological staging of the surgical specimens, 11 (68.7%) had focal invasion of the prostate capsule and five (31.25%) had organ-confined disease. CONCLUSION: Well-differentiated tumors (Gleason score 2 to 4) seen in biopsies are not predictive of organ-confined disease.info:eu-repo/semantics/openAccessAssociação Paulista de Medicina - APMSao Paulo Medical Journal v.126 n.2 20082008-03-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000200010en10.1590/S1516-31802008000200010
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Cury,José
Coelho,Rafael Ferreira
Srougi,Miguel
spellingShingle Cury,José
Coelho,Rafael Ferreira
Srougi,Miguel
Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease
author_facet Cury,José
Coelho,Rafael Ferreira
Srougi,Miguel
author_sort Cury,José
title Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease
title_short Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease
title_full Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease
title_fullStr Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease
title_full_unstemmed Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease
title_sort well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease
description CONTEXT AND OBJECTIVE: Accurate determination of the Gleason score in prostate core biopsy specimens is crucial in selecting the type of prostate cancer treatment, especially for patients with well-differentiated tumors (Gleason score 2 to 4). For such patients, an inaccurate biopsy score may result in a therapeutic intervention that is too conservative. We evaluate the role of Gleason score 2-4 in prostate core-needle biopsies for predicting the final pathological staging following radical prostatectomy. DESIGN AND SETTING: Retrospective study at Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo. METHODS: We analyzed the medical records of 120 consecutive patients who underwent radical retropubic prostatectomy to treat clinical localized prostate cancer at our institution between December 2001 and July 2006. Thirty-two of these patients presented well-differentiated tumors (Gleason score 2 to 4) in biopsy specimens and were included in the study. The Gleason scores of the core-needle biopsies were compared with the pathological staging of the surgical specimens. RESULTS: Sixteen of the 32 patients (50%) presented moderately differentiated tumors (Gleason score 5 to 7) in surgical specimens. Eighteen patients (56%) had tumors with involvement of the prostate capsule and ten (31%) had involvement of adjacent organs. Evaluating the 16 patients that maintained Gleason scores of 2 to 4 in the pathological staging of the surgical specimens, 11 (68.7%) had focal invasion of the prostate capsule and five (31.25%) had organ-confined disease. CONCLUSION: Well-differentiated tumors (Gleason score 2 to 4) seen in biopsies are not predictive of organ-confined disease.
publisher Associação Paulista de Medicina - APM
publishDate 2008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000200010
work_keys_str_mv AT curyjose welldifferentiatedprostatecancerincorebiopsyspecimensmaybeassociatedwithextraprostaticdisease
AT coelhorafaelferreira welldifferentiatedprostatecancerincorebiopsyspecimensmaybeassociatedwithextraprostaticdisease
AT srougimiguel welldifferentiatedprostatecancerincorebiopsyspecimensmaybeassociatedwithextraprostaticdisease
_version_ 1756421528261492736